Feed Top Reports Pricing

⌘K

00:15:05·424d

SECFiling

SEC Form EFFECT filed by Singular Genomics Systems Inc.

OMIC· Singular Genomics Systems Inc.

Industrials

Original source

Companies

OMIC
Singular Genomics Systems Inc.
Industrials

Recent analyst ratings

Aug 17UpdateUBS$4.50
Aug 10UpdateGoldman$3.50
Aug 10UpdateBofA Securities$3.00
Jan 7UpdateBofA Securities$21.00
Oct 15UpdateCowen-

Related

INSIDER420d
Large owner Tang Kevin returned 372,000 shares to the company (SEC Form 4)
SEC420d
Singular Genomics Systems Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Material Modification to Rights of Security Holders, Changes in Control of Registrant
SEC422d
Amendment: SEC Form SCHEDULE 13D/A filed by Singular Genomics Systems Inc.
INSIDER422d
Chief Executive Officer Spaventa Andrew returned 143,310 shares to the company, closing all direct ownership in the company (SEC Form 4)
INSIDER422d
Chief Financial Officer Meeter Dalen returned 9,502 shares to the company, closing all direct ownership in the company (SEC Form 4)
INSIDER422d
Chief Scientific Officer Glezer Eli N. returned 155,583 shares to the company, closing all direct ownership in the company (SEC Form 4)
INSIDER422d
Chief Operating Officer Ghai Jyotsna returned 3,283 shares to the company, closing all direct ownership in the company (SEC Form 4)
INSIDER422d
SEC Form 4 filed by Director Ryan Jason

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022